ArticleCancers2022

CYP1B1: A Novel Molecular Biomarker Predicts Molecular Subtype, Tumor Microenvironment, and Immune Response in 33 Cancers.

Benchao Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.